Back to search
FDAFDA · Food and drugs·Recall number Z-1802-2013

BD BBL BBE // CDC Anaerobe Laked Sheep Blood Agar with KV, packaged in cartons of 100 plates, Catalog # 297260, and labeled in part ***Becton, Dickinson and Company 7 Loveton Circle Sparks, MD 21152 USA 800-638-8663 www.bd.com/ds*** Bacteroides Bile Esculin Agar (BBE) is recommended as a primary isolation medium for the selection and presumptive identification of the B. fragilis group.

Published July 31, 2013 · Recall initiated: June 6, 2013

Summary

FDA records medical device Class II recall Z-1802-2013, published July 31, 2013 and initiated June 6, 2013. Recalling firm: Becton Dickinson & Co.; Status: Terminated; Reported quantity: 42 cartons; Lot: Lot 3071112 Exp 5/28/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbiological identification media may exhibit reduced levels of Vancomycin.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Becton Dickinson & Co.
Distributor
Worldwide distribution: US (nationwide) and countries of:Belgium, Canada, Columbia, Mexico, Singapore, and Taiwan.
Lot
Lot 3071112 Exp 5/28/13
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BD BBL BBE // CDC Anaerobe Laked Sheep Blood Agar with KV, packaged in cartons of 100 plates, Catalog # 297260, and labeled in part ***Becton, Dickinson and Company 7 Loveton Circle Sparks, MD 21152 USA 800-638-8663 www.bd.com/ds*** Bacteroides Bile Esculin Agar (BBE) is recommended as a primary isolation medium for the selection and presumptive identification of the B. fragilis group. recalled?

Yes. FDA published recall Z-1802-2013 on July 31, 2013. Reported hazard: Microbiological identification media may exhibit reduced levels of Vancomycin.

What should I do if I have this product?

Voluntary: Firm initiated · Letter